✦ LIBER ✦

A Phase II study of IncelTM (biricodar, VX-710) in combination with paclitaxel in women with advanced breast cancer refractory to paclitaxel

✍ Scribed by Toppmeyer, D.; Seidman, A.; Overmoyer, B.; Pollak, M.; Verma, S.; Russell, C.; Tkaczuk, K.; Del Prete, S.; Schwartz, G.; Harding, M.W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Study of the MDR Inhibitor Bi

✍ Michael V. Seiden; Kenneth D. Swenerton; Ursula Matulonis; Susan Campos; Peter R 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 88 KB

A Phase II study of the safety, pharmaco

✍ Einstein, A.; Lush, R.; Rago, R.; Bubley, G.; Henner, W.D.; Chatta, G.; Shepard, 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Dose intensification of mitoxantrone in

✍ Francesco Di Costanzo; Andrea Sdrobolini; Luigi Manzione; Domenico Bilancia; Lui 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 42 KB

A phase II study of paclitaxel in advanc

✍ G. Fountzilas; A. Athanassiades; T. Giannakakis; D. Bafaloukos; K. Karakousis; N 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 607 KB

Vinorelbine-induced neurotoxicity in pat

✍ B. Fazeny; U. Zifko; Siegfried Meryn; Heinz Huber; Wolfgang Grisold; Christian D 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 135 KB

P316 Phase II study of weekly albumin-bo

✍ X. Hu; B. Wang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB